A vancomycin-resistant Staphylococcus aureus (VRSA) isolate is identified from a diabetic foot ulcer. The vancomycin MIC is 256 μg/mL. PCR confirms the presence of the vanA gene. The mechanism of vancomycin resistance in this isolate is:
- A Thickening of the peptidoglycan layer trapping vancomycin molecules
- B Acquisition of the vanA operon from vancomycin-resistant enterococci ✓
- C Overexpression of efflux pumps that expel vancomycin
- D Mutation in the vanSR two-component system without vanA acquisition
Explanation
VRSA strains have acquired the vanA operon from VRE via plasmid transfer, leading to synthesis of D-Ala-D-Lac instead of D-Ala-D-Ala, which reduces vancomycin binding affinity by 1000-fold. Option A describes VISA (vancomycin-intermediate S. aureus), not VRSA. Option C is not the mechanism for vancomycin resistance in S. aureus. Option D describes a VISA phenotype with thickened cell wall, not true VRSA with vanA.
Reference: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.